CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trial of CBD-based Formula Targeting Opioid Addiction

Earth Science Tech, Inc. (OTC: ETST) this morning reported that it has finalized preparations for its nine-month human trial to evaluate the effectiveness of a blend of broad-spectrum cannabinoid industrial hemp oil and essential mineral element. The trial seeks to develop a CBD formulation for the treatment of opioid addicts, relieving withdrawal symptoms, and averting fatal overdoses. ETST aims to increase the potency of its formulation by combining its full-spectrum cannabinoids industrial hemp oil with essential minerals. The trial is scheduled to be completed in 2019 and it will be supervised by ETST chief learning officer Gabriel Aviles and CEO Dr. Michel Aube. Per the update, ETST is prepared to manufacture and introduce new products in the market to combat the current scourge of opioid deaths in America if the formulation proves successful. ETST is currently collaborating with CGMP laboratory to mix the anti-opioid formula for the human trials, and it is in talk with rehabilitation centers that are interested in participating in the project.

To view the full press release, visit

About Earth Science Tech, Inc. 

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil. To learn more and to buy CBD Hemp Oil, please visit:

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

Leave a Reply